The Albus is a program whose aim is to foster the creation of a scientific network and to increase the knowledge in the use of albumin as a therapeutic product. By supporting this program Grifols demonstrates its commitment to innovation in this field. We consider the program to be a tangible contribution to the improvement of standards and benefits for the patient care.

Applications for ALBUS 2025 will be accepted between 01/11/2024 and 31/05/2025.

Please click here to apply.

To see the 2024 ALBUS Award winner please click here.